Journal of Community Medicine & Health Education
Open Access

Steven D Weitman

Cancer Therapy & Research Center, The University of Texas Health Science Center at San Antonio, USA

Biography

Steve obtained his M.D. and Ph.D. at the Medical College of Wisconsin. He is a Pediatric Hematology/Oncologist with about 25 years of experience in cancer drug development. Steve is currently Professor at the Institute for Drug Development at UT Health San Antonio.  He was previously Chief Medical Officer, Senior Vice President, and Member of the Executive Committee at ILEX Oncology where he led ILEX’s successful development of clofarabine (Clolar™) and guided that product through a successful ODAC and FDA approval.

Publications

Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives

Background: Inclusion of minorities in clinical research is an essential step to develop novel cancer treatments, improve health care overall, understand potential differences in pharmacogenomics and address minorities’ disproportionate cancer burden. However, Latinos and other minority groups continue to be critically underrepresented, parti... Read More»

Patricia Chalela, Lucina Suarez, Edgar Muñoz, Kipling J Gallion, Brad H Pollock, Steven D Weitman, Anand Karnad and Amelie G Ramirez

Research Article: J Community Med Health Educ 2014, 4:281

DOI: 10.4172/2161-0711.1000281

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article